Targeting Bcl-2 for cancer therapy

被引：90
作者：
Zhang, Linlin [1 ]
Lu, Zaiming [1 ]
Zhao, Xiangxuan [1 ]
机构：
[1] China Med Univ, Dept Radiol, Shengjing Hosp, 36 Sanhao St, Shenyang 110004, Liaoning, Peoples R China
来源：
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2021年 / 1876卷 / 01期
基金：
中国国家自然科学基金;
关键词：
Bcl-2; Apoptosis; Cancer; Target therapy; Drug resistance; CELL LUNG-CANCER; PAN-BCL-2 FAMILY ANTAGONIST; ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; OBATOCLAX MESYLATE GX15-070; CISPLATIN-INDUCED APOPTOSIS; ADVANCED BREAST-CANCER; BH3 MIMETIC ABT-199; PHASE-I TRIAL; PROMOTES APOPTOSIS;
D O I：
10.1016/j.bbcan.2021.188569
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Apoptosis deficiency is one of the most important features observed in neoplastic diseases. The Bcl-2 family is composed of a subset of proteins that act as decisive apoptosis regulators. Research and clinical studies have both demonstrated that the hyperactivation of Bcl-2-related anti-apoptotic effects correlates with cancer occurrence, progression and prognosis, also having a role in facilitating the radio- and chemoresistance of various malignancies. Therefore, targeting Bcl-2 inactivation has provided some compelling therapeutic advantages by enhancing apoptotic sensitivity or reversing drug resistance. Therefore, this pharmacological route turned into one of the most promising routes for cancer treatment. This review discusses some of the well-defined and emerging roles of Bcl-2 as well as its potential clinical value in cancer therapeutics.
引用
收藏
页数：17
相关论文
共 251 条
[1]   The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression [J].
Abraham, M. ;
Klein, S. ;
Bulvik, B. ;
Wald, H. ;
Weiss, I. D. ;
Olam, D. ;
Weiss, L. ;
Beider, K. ;
Eizenberg, O. ;
Wald, O. ;
Galun, E. ;
Avigdor, A. ;
Benjamini, O. ;
Nagler, A. ;
Pereg, Y. ;
Tavor, S. ;
Peled, A. .
LEUKEMIA, 2017, 31 (11) :2336-2346
[2]   A nticancer effect of dentatin and dentatin-hydroxypropyl-β-cyclodextrin complex on human colon cancer (HT-29) cell line [J].
AL-Abboodi, Ashwaq Shakir ;
Rasedee, Abdullah ;
Abdul, Ahmad Bustamam ;
Taufiq-Yap, Yun Hin ;
Alkaby, Wafaa Abd Alwahed ;
Ghaji, Mostafa Saddam ;
Waziri, Peter M. ;
Al-Qubaisi, Mothanna Sadiq .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 :3309-3319
[3]   Corn Silk (Zea mays L.) Induced Apoptosis in Human Breast Cancer (MCF-7) Cells via the ROS-Mediated Mitochondrial Pathway [J].
Al-Oqail, Mai M. ;
Al-Sheddi, Ebtesam S. ;
Farshori, Nida N. ;
Al-Massarani, Shaza M. ;
Al-Turki, Eman A. ;
Ahmad, Javed ;
Al-Khedhairy, Abdulaziz A. ;
Siddiqui, Maqsood A. .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 2019
[4]   Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia [J].
Aldoss, Ibrahim ;
Zhang, Jianying ;
Pillai, Raju ;
Shouse, Geoffrey ;
Sanchez, James F. ;
Mei, Matthew ;
Nakamura, Ryotaro ;
Stein, Anthony S. ;
Forman, Stephen J. ;
Marcucci, Guido ;
Pullarkat, Vinod .
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (02) :E45-E48
[5]   Constitutive expression of Bcl-2 induces epithelial-Mesenchymal transition in mammary epithelial cells [J].
An, Juan ;
Lv, Jin ;
Li, Aimin ;
Qiao, Junxiao ;
Fang, Liang ;
Li, Zhihua ;
Li, Bo ;
Zhao, Wei ;
Chen, Huoming ;
Wang, Liying .
BMC CANCER, 2015, 15
[6]   Apoptotic activity of xanthoquinodin JBIR-99, from Parengyodontium album MEXU 30054, in PC-3 human prostate cancer cells [J].
Anaya-Eugenio, Gerardo D. ;
Rebollar-Ramos, Daniela ;
del Carmen Gonzalez, Maria ;
Raja, Huzefa ;
Mata, Rachel ;
Carcache de Blanco, Esperanza J. .
CHEMICO-BIOLOGICAL INTERACTIONS, 2019, 311
[7]   Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt [J].
Asnaghi, L ;
Calastretti, A ;
Bevilacqua, A ;
D'Agnano, I ;
Gatti, G ;
Canti, G ;
Delia, D ;
Capaccioli, S ;
Nicolin, A .
ONCOGENE, 2004, 23 (34) :5781-5791
[8]  
Baev Denis V, 2014, Leuk Res Rep, V3, P79, DOI 10.1016/j.lrr.2014.06.001
[9]   BM-1197: A Novel and Specific Bcl-2/Bcl-xL Inhibitor Inducing Complete and Long-Lasting Tumor Regression In Vivo [J].
Bai, Longchuan ;
Chen, Jianfang ;
McEachern, Donna ;
Liu, Liu ;
Zhou, Haibin ;
Aguilar, Angelo ;
Wang, Shaomeng .
PLOS ONE, 2014, 9 (06)
[10]   A Controlled Study of a Lecithinized Delivery System of Curcumin (Meriva®) to Alleviate the Adverse Effects of Cancer Treatment [J].
Belcaro, Gianni ;
Hosoi, Morio ;
Pellegrini, Luciano ;
Appendino, Giovanni ;
Ippolito, Edmondo ;
Ricci, Andrea ;
Ledda, Andrea ;
Dugall, Mark ;
Cesarone, Maria Rosaria ;
Maione, Claudia ;
Ciammaichella, Giovanna ;
Genovesi, Domenico ;
Togni, Stefano .
PHYTOTHERAPY RESEARCH, 2014, 28 (03) :444-450
12345678910